LUNG NEUROENDOCRINE NEOPLASM
Clinical trials for LUNG NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new LUNG NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for LUNG NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a One-Two punch of radiation and immune therapy better fight lung cancer?
Disease control OngoingThis study is testing if combining a targeted, high-dose radiation treatment with an immunotherapy drug works better than radiation alone for certain early-stage or recurrent non-small cell lung cancers. About 140 participants will be randomly assigned to receive either the radia…
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New pill targets rare, Hard-to-Treat cancers
Disease control OngoingThis study is testing an experimental oral drug called CVM-1118 for people with advanced neuroendocrine tumors that have stopped responding to standard treatments. The main goal is to see if the drug can slow or stop the cancer from growing. Researchers will also closely monitor …
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC
-
Major study aims to map the best path for treating rare tumors
Knowledge-focused OngoingThis study aims to understand how different treatment sequences affect the quality of life and symptoms of people with neuroendocrine tumors (NETs). Researchers will follow over 2,500 patients for up to five years, linking their survey answers about their health and treatment exp…
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC